Immutep Limited (YP1A) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.086x

Based on the latest financial reports, Immutep Limited (YP1A) has a cash flow conversion efficiency ratio of -0.086x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.72 Million ≈ $-13.70 Million USD) by net assets (€136.47 Million ≈ $159.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See YP1A net asset quality score to measure how much of total assets are equity-financed.

Immutep Limited - Cash Flow Conversion Efficiency Trend (2017–2023)

This chart illustrates how Immutep Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore YP1A debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Immutep Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Immutep Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
China Bicycle Co Holdings Ltd SHE:200017	-0.043x
Elicio Therapeutics Inc. NASDAQ:ELTX	8.104x
Wahana Ottomitra Multiartha JK:WOMF	-0.049x
CSL Finance Limited NSE:CSLFINANCE	-0.081x
Cloud Air Co.Ltd KQ:036170	0.001x
Byuksan Corp KO:007210	0.012x
COWELL FASHION Co.Ltd KQ:033290	0.031x
BenQ Medical Technology TWO:4116	0.084x

Annual Cash Flow Conversion Efficiency for Immutep Limited (2017–2023)

The table below shows the annual cash flow conversion efficiency of Immutep Limited from 2017 to 2023. For the full company profile with market capitalisation and key ratios, see YP1A market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-06-30	€136.47 Million ≈ $159.55 Million	€-35.36 Million ≈ $-41.33 Million	-0.259x	-17.20%
2022-06-30	€136.76 Million ≈ $159.88 Million	€-30.23 Million ≈ $-35.34 Million	-0.221x	+8.19%
2021-06-30	€73.27 Million ≈ $85.66 Million	€-17.64 Million ≈ $-20.62 Million	-0.241x	+26.04%
2020-06-30	€33.30 Million ≈ $38.93 Million	€-10.84 Million ≈ $-12.67 Million	-0.326x	+48.07%
2019-06-30	€24.39 Million ≈ $28.51 Million	€-15.29 Million ≈ $-17.87 Million	-0.627x	-170.19%
2018-06-30	€33.52 Million ≈ $39.19 Million	€-7.78 Million ≈ $-9.09 Million	-0.232x	+27.64%
2017-06-30	€26.53 Million ≈ $31.02 Million	€-8.51 Million ≈ $-9.95 Million	-0.321x	--

About Immutep Limited

F:YP1A Germany Biotechnology

Market Cap

$53.41 Million

€45.69 Million EUR

Market Cap Rank

#21596 Global

#1930 in Germany

Share Price

€0.31

Change (1 day)

-0.64%

52-Week Range

€0.24 - €2.64

All Time High

€4.52